O75530 (EED_HUMAN) Homo sapiens (Human)

Polycomb protein EED UniProtKBInterProSTRINGInteractive Modelling

441 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3); 64 identical sequences

Available Structures

68 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of EED [G255D] in complex with EZH2 peptide and EED226 compound Heteromer
Q15910;
76-441
GOL;73K;
Assess
EED in complex with an allosteric PRC2 inhibitor EED666 Heteromer
Q15910;
76-440
GOL;LQB;
Assess
Crystal Structure of EED in complex with EB22 Heteromer
77-441
16×UNX;
Assess
Structure of Human Polycomb Repressive Complex 2 (PRC2) with oncogenic histone H3K27M peptide Heteromer
P68431; Q15022; Q15910; Q92833;
77-441
ZN;SAH;
Assess
Structure of human PRC2-EZH1 containing phosphorylated SUZ12 Heteromer
Q15022; Q92800;
77-441
ZN;SAM;
Assess
Structure of Human Polycomb Repressive Complex 2 (PRC2) with inhibitor Heteromer
Q15022; Q15910; Q92833;
77-441
ZN;74D;
Assess
PRC2:EZH1_A from a dimeric PRC2 bound to a nucleosome Heteromer
Q09028; Q15022; Q92800;
76-440
ZN;
Assess
Cryo-EM structure of PRC2:EZH1-AEBP2-JARID2 Heteromer
Q09028; Q15022; Q6ZN18; Q92800; Q92833;
76-440
ZN;
Assess
PRC2:EZH1_B from a dimeric PRC2 bound to a nucleosome Heteromer
Q09028; Q15022; Q92800;
76-440
ZN;
Assess
EED in complex with PRC2 allosteric inhibitor compound 6 Heteromer
Q15910;
77-440
CL;EKR;
Assess
EED in complex with PRC2 allosteric inhibitor compound 7 Heteromer
Q15910;
77-440
CL;EKF;
Assess
Crystal structure of EED in complex with EZH2 peptide and compound 11# Heteromer
Q15910;
77-440
EJU;
Assess
EED in complex with PRC2 allosteric inhibitor EED210 Heteromer
Q15910;
77-440
LQE;
Assess
EED in complex with PRC2 allosteric inhibitor compound 8 Heteromer
Q15910;
77-440
LQG;
Assess
EED in complex with PRC2 allosteric inhibitor compound 11 Heteromer
Q15910;
77-440
LQH;
Assess
Crystal Structure of an EZH2-EED Complex in an Oligomeric State Heteromer
Q15910;
78-441
Assess
EED in complex with PRC2 allosteric inhibitor compound 22 (MAK683) Heteromer
Q15910;
78-440
CL;EJR;
Assess
EED in complex with PRC2 allosteric inhibitor EED162 Heteromer
Q15910;
78-440
LQF;
Assess
EED in complex with PRC2 allosteric inhibitor EED709 Heteromer
Q15910;
78-440
LQD;
Assess
EED in complex with an allosteric PRC2 inhibitor Heteromer
Q15910;
78-440
73K;
Assess
Crystal structure of EED in complex with H3K27Me3 peptide and 3-(benzo[d][1,3]dioxol-4-ylmethyl)pip… Heteromer
Q15910;
79-440
7W7;
Assess
Crystal structure of EED in complex with H3K27Me3 peptide and 6-(benzo[d][1,3]dioxol-4-ylmethyl)-5,… Heteromer
Q15910;
79-440
GOL;YT3;7WD;
Assess
PRC2-AEBP2-JARID2 bound to H2AK119ub1 nucleosome Heteromer
P02281; P06897; P0CG48; P62799; P84233; Q09028; Q15022; Q15910; Q6ZN18; Q92833;
80-441
MG;SAH;ZN;
Assess
Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Extended Active State Heteromer
Q09028; Q15022; Q15910; Q6ZN18; Q92833;
80-441
Assess
Cryo-EM structure of PRC2 bound to cofactors AEBP2 and JARID2 in the Compact Active State Heteromer
Q09028; Q15022; Q15910; Q6ZN18; Q92833;
80-441
Assess
Structure of Hs/AcPRC2 in complex with a pyridone inhibitor Heteromer
G1KPH4; Q15022;
81-440
6BN;ZN;
Assess
Human Polycomb Repressive Complex 2 in complex with GSK126 inhibitor Heteromer
Q15022; Q15910;
81-440
ZN;A9G;
Assess
Crystal structure of EED in complex with PALI1-K1219me3 peptide Heteromer
Q96JN0;
81-439
Assess
Crystal structure of EED in complex with PALI1-K1241me3 peptide Heteromer
Q96JN0;
81-439
Assess
Structural basis of EZH2 recognition by EED Heteromer
Q61188; Q921E6;
82-440
Assess
EED: A Novel Histone Trimethyllysine Binder Within The EED-EZH2 Polycomb Complex Heteromer
P62805;
81-439
Assess
Crystal structure of Eed in complex with a trimethylated histone H4K20 peptide Heteromer
P62805;
81-439
Assess
Structure of Hs/AcPRC2 in complex with 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin… Heteromer
G1KPH4; Q15022;
82-440
ZN;CJD;
Assess
Structure of the primary oncogenic mutant Y641N Hs/AcPRC2 in complex with a pyridone inhibitor Heteromer
G1KPH4; Q15022;
82-440
6BN;ZN;
Assess
Structure of Hs/AcPRC2 in complex with 5,8-dichloro-7-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(4,6-dimeth… Heteromer
G1KPH4; Q15022;
82-440
ZN;CJG;
Assess
EED in complex with PRC2 allosteric inhibitor EED396monomer76-440
GOL;PR;LQA;
Assess
Crystal structure of human EEDmonomer77-441
XB7; 27×UNX;
Assess
Crystal structure of Eed in complex with a trimethylated histone H1K26 peptidemonomer77-440
Assess
Crystal Structure of EED in Complex with UNC4859monomer79-440
SO4; 11×UNX;
Assess
Crystal structure of EED in complex with 6-(2-fluoro-5-methoxybenzyl)-1-isopropyl-5,6,7,8-tetrahydr…monomer79-440
7VV;GOL;
Assess
Crystal structure of EED in complex with 3-(3-methoxybenzyl)piperidine hydrochloridemonomer79-440
FMT;7VY;
Assess
CRYSTAL STRUCTURE OF EED WITH MRTX-1919monomer80-440
NA;9L0;EDO; 13×FMT;
Assess
Crystal structure of Eed in complex with NDSB-195monomer80-440
NDS;
Assess
Complex structure of EED and trimethylated H3K4monomer80-439
Assess
Complex structure of EED and trimethylated H3K9monomer80-439
Assess
CRYSTAL STRUCTURE OF EED WITH MRTX-2219monomer81-440
9JL;FMT;
Assess
Crystal structure of Eed in complex with a trimethylated histone H3K27 peptidemonomer81-439
Assess
Targeting the PRC2 complex through a novel protein-protein interaction inhibitor of EEDmonomer82-440
6PU;
Assess
Structure of EED bound to inhibitor 1056monomer81-439
Q3A;NA;FMT;
Assess
Structure of EED bound to EEDi-4259monomer81-439
ZNG;
Assess
EED-H3K79me3monomer81-439
Assess
Structure of EED in complex with H3K27me3monomer81-439
Assess
Structure of EED bound to inhibitor 5285monomer81-439
Q3D;GOL;
Assess
Structure of EED bound to EEDi-6068monomer81-439
ZMY;FMT;
Assess
Crystal structure of EED in complex with a trimethylated Jarid2 peptidemonomer81-439
Assess
Crystal structure of Eed in complex with a trimethylated histone H3K9 peptidemonomer81-439
Assess
Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-methoxyphenyl)methyl]-N,N-dimethyl-4-…monomer82-439
LQD;
Assess
Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]…monomer82-439
82G;
Assess
Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-bromo-6-fluorophenyl)methyl]-N,N-dime…monomer82-439
82D;
Assess
EED in complex with a triazolopyrimidinemonomer82-439
L9W;
Assess
EED in complex with compound 4monomer82-439
L9W;
Assess
Polycomb protein EED in complex with inhibitor: 2-[4-(4-{(3S,4R)-4-(dimethylamino)-1-[(2-fluoro-6-m…monomer82-439
7XG;
Assess
EED in complex with a triazolopyrimidinemonomer82-439
L9W;
Assess
EED in complex with compound 4monomer82-439
MG;L9W;
Assess
EED in complex with a methyl-thiazolemonomer82-439
CA;L9W;
Assess
EED in complex with a cyano-benzofuranmonomer82-439
CA;L9W;
Assess
EED in complex with compound 4monomer82-439
L9W;
Assess
Structure of EED in apo formmonomer82-439
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7kxt.2.Amonomer0.8680-440
XB7;100.00
Assess
5obm.152.Amonomer0.5418-394
14.43
Assess

5 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27ksr.1.Dmonomer0.7376-465
99.09
Assess
Isoform 27cz5.1.Dmonomer0.5321-415
15.00
Assess
Isoform 35wg6.1.Bmonomer0.8281-400
100.00
Assess
Isoform 34kzz.1.6monomer0.5620-335
13.00
Assess
Isoform 34kzz.1.6monomer0.5483-393
15.46
Assess